Malaria vaccine: GSK announces a product transfer agreement with Bharat Biotech
by Press Release from Outbreak News Today on (#5DE89)
By NewsDesk @infectiousdiseasenews GSK, PATH, and Bharat Biotech (BBIL) Wednesday announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes the transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to BBIL. GSK [...]
The post Malaria vaccine: GSK announces a product transfer agreement with Bharat Biotech appeared first on Outbreak News Today.